{"id":"intramuscular-methylprednisolone-acetate","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Insomnia"},{"rate":null,"effect":"Mood changes"},{"rate":null,"effect":"Immunosuppression / increased infection risk"},{"rate":null,"effect":"Osteoporosis with chronic use"},{"rate":null,"effect":"Injection site reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Methylprednisolone acetate binds to glucocorticoid receptors in the cytoplasm, translocating to the nucleus to modulate gene expression of pro-inflammatory cytokines, chemokines, and adhesion molecules. This results in decreased recruitment and activation of immune cells, reduced vascular permeability, and suppression of both humoral and cell-mediated immune responses. The acetate ester formulation provides sustained release when administered intramuscularly.","oneSentence":"Methylprednisolone acetate is a corticosteroid that suppresses the immune system and reduces inflammation by inhibiting inflammatory mediators and immune cell activation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:48:41.012Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory and autoimmune conditions responsive to corticosteroid therapy"},{"name":"Rheumatoid arthritis"},{"name":"Lupus and other connective tissue diseases"},{"name":"Severe allergic reactions"}]},"trialDetails":[{"nctId":"NCT07245732","phase":"PHASE4","title":"Oral Versus Intramuscular Steroid Use to Control Rheumatoid Arthritis Flares","status":"NOT_YET_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2026-04","conditions":"Rheumatoid Arthritis (RA)","enrollment":220},{"nctId":"NCT07005154","phase":"PHASE2","title":"A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer","status":"RECRUITING","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2025-06-19","conditions":"Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer","enrollment":218},{"nctId":"NCT00400946","phase":"PHASE3","title":"05-001: Treatment of Acute Lymphoblastic Leukemia in Children","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2005-04","conditions":"Drug/Agent Toxicity by Tissue/Organ, Leukemia","enrollment":800},{"nctId":"NCT07371572","phase":"PHASE3","title":"The Efficacy and Safety of Intramuscular Methylprednisolone in Patients With Hand OsteoArthritis","status":"RECRUITING","sponsor":"Sint Maartenskliniek","startDate":"2025-10-28","conditions":"Hand Osteoarthritis","enrollment":212},{"nctId":"NCT03368664","phase":"PHASE3","title":"A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT","status":"TERMINATED","sponsor":"Genzyme, a Sanofi Company","startDate":"2017-10-24","conditions":"Multiple Sclerosis","enrollment":16},{"nctId":"NCT06057012","phase":"PHASE2","title":"A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD)","status":"COMPLETED","sponsor":"Brii Biosciences Limited","startDate":"2023-09-29","conditions":"Severe Postpartum Depression","enrollment":11},{"nctId":"NCT05843968","phase":"PHASE2","title":"Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Nephrotic Syndrome","status":"RECRUITING","sponsor":"Children's Hospital of Chongqing Medical University","startDate":"2023-01-29","conditions":"Nephrotic Syndrome in Children","enrollment":46},{"nctId":"NCT04622917","phase":"PHASE4","title":"Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis.","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2019-04-10","conditions":"Rhinitis, Allergic, Seasonal, Hay Fever, Pollen Allergy","enrollment":44},{"nctId":"NCT03355482","phase":"PHASE2","title":"MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLE","status":"TERMINATED","sponsor":"Oklahoma Medical Research Foundation","startDate":"2017-04-10","conditions":"Systemic Lupus Erythematosus Arthritis","enrollment":9},{"nctId":"NCT01186328","phase":"PHASE1","title":"EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)","status":"TERMINATED","sponsor":"Therapeutic Advances in Childhood Leukemia Consortium","startDate":"2010-08-24","conditions":"Lymphoblastic Leukemia, Acute, Lymphoblastic Leukemia, Acute, Childhood, Leukemia, Lymphoblastic, Acute, T Cell","enrollment":6},{"nctId":"NCT01838174","phase":"PHASE4","title":"A Trial of Neuroprotection With ACTH in Acute Optic Neuritis","status":"TERMINATED","sponsor":"University of Colorado, Denver","startDate":"2013-05","conditions":"Multiple Sclerosis","enrollment":37},{"nctId":"NCT05793359","phase":"","title":"Comparison of the Effectiveness of Two Glucocorticoid Regimens for Treatment of Graves' Orbitopathy","status":"COMPLETED","sponsor":"Medical University of Sofia","startDate":"2017-07-25","conditions":"Graves Ophthalmopathy","enrollment":62},{"nctId":"NCT05413902","phase":"PHASE4","title":"Multi-Modal Anesthesia Protocol in Pain Management of Patients Undergoing Posterior Lumbar Spinal Fusion Surgery","status":"COMPLETED","sponsor":"University of Puerto Rico","startDate":"2021-04-05","conditions":"Pain Management, Posterior Spinal Fusion","enrollment":100},{"nctId":"NCT00290589","phase":"PHASE3","title":"A Trial of Corticosteroids for Low Back Pain","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2003-06","conditions":"Radicular Low Back Pain","enrollment":82},{"nctId":"NCT02847494","phase":"PHASE4","title":"Corticosteroids for Acute Migraine in the Emergency Department","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2016-09-01","conditions":"Migraine","enrollment":220},{"nctId":"NCT00957801","phase":"PHASE4","title":"Anabolic and Inflammatory Responses to Short-Term Testosterone Administration in Older Men","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2009-03","conditions":"Sarcopenia","enrollment":29},{"nctId":"NCT02904772","phase":"PHASE2","title":"Alipogene Tiparvovec for the Treatment of LPLD Patients","status":"WITHDRAWN","sponsor":"UniQure Biopharma B.V.","startDate":"2016-10","conditions":"LPL Deficiency","enrollment":""},{"nctId":"NCT00282308","phase":"PHASE2","title":"A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2006-01-23","conditions":"Rheumatoid Arthritis","enrollment":103},{"nctId":"NCT02479581","phase":"PHASE2","title":"The Safety and Efficacy of the Enhanced Recovery After Surgery(ERAS)Applied on Cardiac Surgery With Cardiopulmonary Bypass","status":"COMPLETED","sponsor":"Xiangya Hospital of Central South University","startDate":"2015-07","conditions":"Valvular Heart Disease","enrollment":226},{"nctId":"NCT03152474","phase":"PHASE4","title":"Adrenal Cortical Function and Vitamin A Deficiency in Sepsis","status":"COMPLETED","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"1993-02","conditions":"Sepsis","enrollment":300},{"nctId":"NCT01049451","phase":"PHASE1","title":"Pulse ACTH vs. MP for MS","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2009-11","conditions":"Multiple Sclerosis","enrollment":23},{"nctId":"NCT00947895","phase":"PHASE2, PHASE3","title":"Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone","status":"TERMINATED","sponsor":"Neurologique Foundation, Inc.","startDate":"2009-10","conditions":"Multiple Sclerosis","enrollment":30},{"nctId":"NCT00298272","phase":"PHASE2","title":"Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis","status":"TERMINATED","sponsor":"Biogen","startDate":"2006-05","conditions":"Rheumatoid Arthritis","enrollment":54},{"nctId":"NCT01071083","phase":"PHASE2","title":"Treatment Interruption of Natalizumab","status":"COMPLETED","sponsor":"Biogen","startDate":"2010-03","conditions":"Relapsing Remitting Multiple Sclerosis","enrollment":175},{"nctId":"NCT00891306","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in LPL-deficient Subjects","status":"COMPLETED","sponsor":"Amsterdam Molecular Therapeutics","startDate":"2009-02","conditions":"Familial Lipoprotein Lipase Deficiency","enrollment":5},{"nctId":"NCT00332696","phase":"PHASE2","title":"Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2005-09","conditions":"Peritoneal Neoplasms, Intestinal Obstruction, Carcinomatosis","enrollment":64},{"nctId":"NCT00241982","phase":"PHASE2","title":"Long-Circulating Liposomal Prednisolone Versus Pulse Intramuscular Methylprednisolone in Patients With Active Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2005-10","conditions":"Rheumatoid Arthritis","enrollment":22}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["steroid"],"phase":"phase_3","status":"active","brandName":"Intramuscular methylprednisolone acetate","genericName":"Intramuscular methylprednisolone acetate","companyName":"Montefiore Medical Center","companyId":"montefiore-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Methylprednisolone acetate is a corticosteroid that suppresses the immune system and reduces inflammation by inhibiting inflammatory mediators and immune cell activation. Used for Inflammatory and autoimmune conditions responsive to corticosteroid therapy, Rheumatoid arthritis, Lupus and other connective tissue diseases.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}